Fundraising Fox

Reyedar

Founded 2020 · 11 employees on LinkedIn · 6 known investors

Reyedar develops an AI-powered eye tracking system that detects biomarkers of neurological and visual health conditions such as glaucoma and Parkinson's disease through automated oculomotor testing. The company serves optometry centers, hospitals, clinics, and clinical research centers seeking rapid, non-invasive screening for neurovisual disorders.

AI & Machine LearningHealthtechMedical Devices

Founders & leadership

Reyedar was founded in 2020 by Camiel van Vught.

CVCamiel van Vught
Camiel van VughtinCo-Founder & Commercial Director

Investors · 6

Cottonwood Technology FundDenver · $1M – $25M
NV NOMGroningen
Nomreported

Also in the syndicate · 3

Blue SparrowsPupil LabsUneti Ventures

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Dutch-based Reyedar raises €3M for early detection of neurodegenerative diseases - Silicon Canalssiliconcanals.com · Jul 2023Reyedar Raises €3M in Seed Fundingfinsmes.com · Jul 2023Reyedar (formerly Reperio Medtech) raises €3 million capital to further develop groundbreaking solution for detecting degenerative diseases - nvnom.comnvnom.com · Jul 2023Dutch deep tech start-up Reyedar raises €3 million to commercialise its degenerative disease screening technology - Tech.eutech.eu · Jul 2023

Frequently asked questions

What does Reyedar do?
Reyedar develops an AI-powered eye tracking system that detects biomarkers of neurological and visual health conditions such as glaucoma and Parkinson's disease through automated oculomotor testing. The company serves optometry centers, hospitals, clinics, and clinical research centers seeking rapid, non-invasive screening for neurovisual disorders.
Who founded Reyedar?
Reyedar was founded by Camiel van Vught in 2020.
Who are Reyedar's investors?
Reyedar's investors include Cottonwood Technology Fund, NV NOM, Nom.